A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin α, or the p55TNF-R

Journal of Experimental Medicine

Volumn 188, Issue 7, 1998, Pages 1343-1352

  Douni, Eleni ^a   Kollias, George ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Ligand independent signaling; NF B activation; Sepsis; Transgenic model

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION; TRANSGENE;

ANIMALS; ANTIGENS, CD; CELL EXTRACTS; CELL NUCLEUS; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOTOXIN-ALPHA; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032487514     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.7.1343     Document Type: Article

References (61)

1. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
2. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell. Biol. 5:392-399.
3. Aggarwal, B.B., and K. Natarajan. 1996. Tumor necrosis factors: Developments during the last decade. Eur. Cytokine Netw. 7:93-124.
4. Seckinger, P., S. Isaaz, and J.M. Dayer. 1989. Purification and biologic characterization of a specific tumor necrosis factor a inhibitor J. Biol. Chem. 264:11966-11973.
5. Engelmann, H., D. Novick, and D. Wallach. 1990. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265: 1531-1536.
6. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397-1411.
7. Le Hir, M., H. Bluethmann, M.H. Kosco-Vilbois, M. Muller, F. Di Padova, M. Moore, B. Ryffel, and H.P. Eugster. 1996. Differentiation of follicular dendritic cells and full antibody responses require tumour necrosis factor receptor-1 signalling. J. Exp. Med. 183:2367-2373.
8. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T.W. Mak, B. Holzmann, and M. Kronke. 1996. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587-1593.
9. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 364:798-802.
10. Pfeffer, K., T. Matsuyama, T.M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Kronke, and T.W. Mak. 1993. Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73: 457-467.
11. Ruby, J., H. Bluethmann, and J.J. Peschon. 1997. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J. Exp. Med. 186:1591-1596.
12. Douni, E., K. Akassoglou, L. Alexopoulou, S. Georgopoulos, S. Haralambous, S. Hill, G. Kassiotis, D. Kontoyiannis, M. Pasparakis, D. Plows, et al. 1996. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J. Inflamm. 47:27-38.
13. Akassoglou, K., L. Probert, G. Kontogeorgos, and G. Kollias. 1997. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158: 438-445.
14. Alexopoulou, L., M. Pasparakis, and G. Kollias. 1997. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signalling. Eur. J. Immunol. 27:2588-2592.
15. Probert, L. J. Keffer, P. Corbella, H. Cazlaris, E. Patsavoudi, S. Stephens, E. Kaslaris, D. Kioussis, and G. Kollias. 1993. Wasting, ischemia and lymphoid abnormalities in mice expressing T-cell targeted human tumor necrosis factor transgenes. J. Immunol. 151:1894-1906.
16. Georgopoulos, S., D. Plows, and G. Kollias. 1996. Transmembrane TNF is sufficient to induce localized tissue toxicity and chrome inflammatory arthritis in transgenic mice. J. Inflamm. 46:86-97.
17. Kondo, S., and D.N. Sauder. 1997. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-α-induced skin inflammation. Eur. J. Immunol. 27:1713-1718.
18. Erickson, S.L., F.J. De Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K.C. Sheehan, R.D. Schreiber, D.V. Goeddel, and M.W. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature. 372:560-563.
19. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83:793-802.
20. Grell, M., H. Wajant, G. Zimmermann, and P. Scheurich. 1998. The type 1 receptor (CD120a) is the high-affinity receptor for tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 95:570-575.
21. Vandenabeele, P., W. Declercq, B. Vanhaesebroeck, J. Grooten, and W. Fiers. 1995. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol. 154:2904-2913.
22. Haridas, V., B.G. Darnay, K. Natarajan, R. Heller, and B.B. Aggarwal. 1998. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-κB activation, and c-Jun kinase activation. J. Immunol. 160:3152-3162.
23. Santee, S.M., and L.B. Owen-Schaub. 1996. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J. Biol. Chem. 271:21151-21159.
24. Schroder, J., F. Stuber, H. Gallati, F.U. Schade, and B. Kremer. 1995. Pattern of soluble TNF receptors I and II in sepsis. Infection. 23:143-148.
25. Marinos, G., N.V. Naoumov, S. Rossol, F. Torre, P.Y. Wong, H. Gallati, B. Portmann, and R. Williams. 1995. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterohgy. 108:1453-1463.
26. Lucas, R., J. Lou, D.R. Morel, B. Ricou, P.M. Suter, and G.E. Grau. 1997. TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J. Leukoc. Biol. 61:551-558.
27. De Beaux, A.C., J.A. Goldie, D.C. Ross, D.C. Carter, and K.C.H. Fearon. 1996. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. British J. Surgery. 83:349-353.
28. Gabay, C., N. Cakir, F. Moral, P. Roux-Lombard, O. Meyer, J.M. Dayer, T. Vischer, H. Yazici, and P.A. Guerne. 1997. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J. Rheumatol. 24:303-308.
29. Cope, A.P., D. Aderka, M. Doherty. H. Engelmann, D. Gibbons, A.C. Jones, F.M. Brennan, R.N. Maini, D. Wallach, and M. Feldmann. 1992. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum. 35:1160-1169.
30. Godfried, M.H., T. Van der Poll, J. Jansen, J.A. Romijin, J.K. Schattenkerk, E. Endert, S.J. Van Deventer, and H.P. Sauerwein. 1993. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS (Lond.). 7:33-36.
31. Aderka, D., P. Sorkine, S. Abu-Abid, D. Lev, A. Setton, A.P. Cope, D. Wallach, and J. Klausner. 1998. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. J. Clin. Invest. 101: 650-659.
32. Bohrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jllmer, D. Mannel, B.W. Bottiger, D.M. Stern, R. Waldherr, H.D. Saeger, et al. 1997. Role of NF-κB in the mortality of sepsis. J. Clin. Invest. 100:972-985.
33. Diez-Ruiz, A., G.P. Tilz, R. Zangerle, G. Baier-Bitterlich, H. Wachter, and D. Fuchs. 1995. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur. J. Haematol. 54:1-8.
34. Pasparakis, M., and G. Kollias. 1995. Production of cytokine transgenic and knockout mice. In Cytokines: A Practical Approach. F. Balkwill, editor. IRL Press, Oxford, UK. 297-325.
35. De Togni, P., J. Goellner, N.H. Ruddle, P.R. Streeter, A. Fick, S. Mariathasan, S.C. Smith, R. Carlson, L.P. Shornick, J. Strauss-Schoenberger, et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 264:703-707.
36. Aγ-, β-, and hybrid γβ-globin genes in transgenic mice: manipulation of the developmental expression patterns. Cell. 46:89-94.
37. Grell, M., P. Scheurich, A. Meager, and K. Pfizenmaier. 1993. TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res. 12:143-148.
38. Bemelmans, M.H., D.J. Gouma, and W.A. Buurman. 1993. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibitory factor, and IFN-γ. J. Immunol. 151: 5554-5562.
39. Tomonari, K. 1988. A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics. 28:455-458.
40. Dignam, J.D. 1990. Preparation of extracts from higher eukaryotes. Methods Enzymol. 182:194-203.
41. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
42. Tartaglia, L.A., D.V. Goeddel, C. Reynolds, I.S. Figari, R.F. Weber, B.M. Fendly, and M.A. Palladino, Jr. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151: 4637-4641.
43. Bemelmans, M.H.A., D.J. Gouma, and W.A. Buurman. 1993. Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J. Immunol. 150:2007-2017.
44. Baeuerle, P.A., and D. Baltimore. 1996. NF-κB: ten years after. Cell. 87:13-20.
45. Rothe, M., V. Sarma, V.M. Dixit, and D.V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science. 269:1424-1427.
46. Aderka, D., H. Englemann, V. Hornik, Y. Skornick, Y. Levo, D. Wallach, and G. Kushtai. 1991. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 51:5602-5607.
47. Aderka, D. 1996. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev. 7:231-240.
48. Peschon, J.J., D.S. Torrance, K.L. Stocking, M.B. Glaccum, C. Otten, C.R. Willis, K. Charrier, P.J. Morrissey, C.B. Ware, and K.M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943-952.
49. Lucas, R., P. Juillard, E. Decoster, M. Redard, D. Burger, Y. Donati, C. Giroud, C. Monso-Hmard, T. De Kesel, W.A. Buurman, et al. 1997. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27:1719-1725.
50. Wang, B., H. Fujisawa, L. Zhuang, S. Kondo, G.M. Shivji, C.S. Kim, T.W. Mak, and D.N. Sauder. 1997. Depressed langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 159:6148-6155.
51. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 377:348-351.
52. Tartaglia, L.A., D. Pennica, and D.V. Goeddel. 1993. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268:18542-18548.
53. Weiss, T., M. Grell, B. Hessabi, S. Bourteele, G. Muller, P. Scheurich, and H. Wajant. 1997. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. J. Immunol. 158:2398-2404.
54. Wells, J.A. 1994. Structural and functional basis for hormone binding and receptor oligomerization. Curr. Opin. Cell. Biol. 6:163-173.
55. Pinckard, J.K., K.C. Sheehan, and R.D. Schreiber. 1997. Ligand-induced formation of the p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J. Biol. Chem. 272:10784-10789.
56. Rao, P., K.C. Hsu, and M.V. Chao. 1995. Upregulation of NF-κB dependent gene expression mediated by the p75 tumor necrosis factor receptor. J. Interferon Cytokine Res. 15: 171-177.
57. Boldin, M.P., I.L. Mett, E.E. Varfolomeev, I. Chumakov, Y. Shemer-Avni, J.H. Camonis, and D. Wallach. 1995. Self association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270:387-391.
58. Cheng, G., and D. Baltimore. 1996. TANK, a co-inducer with TRAF2 of TNF-and CD40L-mediated NF-κB activation. Genes Dev. 10:963-973.
59. Rabizadeh, S., J. Oh, L.T. Zhong, J. Yang, C.M. Bitler, L.L. Butcher, and D.E. Bredesen. 1993. Induction of apoptosis by the low-affinity NGF receptor. Science. 261:345-348.
60. Haley, J.D., J.J. Hsuan, and M.D. Waterfield. 1989. Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors. Oncogene. 4:273-283.
61. Grau, G.E., and D.N. Maennel. 1997. TNF inhibition and sepsis-sounding a cautionary note. Nat. Med. 3:1193-1195.